Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.

Delehouzé C, Mallais M, Comte A, Lucas R, Baratte B, Bélal S, Autret A, Py N, Steinschneider R, Adoux L, Saintpierre B, Letourneur F, Robert T, Cougoule C, Bomfim C, Planès R, Péricat D, Bulinski JC, Dimanche-Boitrel MT, Goekjian P, Meunier E, Rousselot M, Pratt DA, Bach S

Open source

DOI: 10.1038/s41420-025-02852-8
Published: 2025 Nov 28
Container: Cell death discovery
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41420-025-02852-8,
  title = {Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.},
  author = {Delehouzé C and Mallais M and Comte A and Lucas R and Baratte B and Bélal S and Autret A and Py N and Steinschneider R and Adoux L and Saintpierre B and Letourneur F and Robert T and Cougoule C and Bomfim C and Planès R and Péricat D and Bulinski JC and Dimanche-Boitrel MT and Goekjian P and Meunier E and Rousselot M and Pratt DA and Bach S},
  year = {2025},
  journal = {Cell death discovery},
  doi = {10.1038/s41420-025-02852-8},
  url = {https://doi.org/10.1038/s41420-025-02852-8}
}

RIS

TY  - JOUR
TI  - Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.
AU  - Delehouzé C
AU  - Mallais M
AU  - Comte A
AU  - Lucas R
AU  - Baratte B
AU  - Bélal S
AU  - Autret A
AU  - Py N
AU  - Steinschneider R
AU  - Adoux L
AU  - Saintpierre B
AU  - Letourneur F
AU  - Robert T
AU  - Cougoule C
AU  - Bomfim C
AU  - Planès R
AU  - Péricat D
AU  - Bulinski JC
AU  - Dimanche-Boitrel MT
AU  - Goekjian P
AU  - Meunier E
AU  - Rousselot M
AU  - Pratt DA
AU  - Bach S
PY  - 2025
JO  - Cell death discovery
DO  - 10.1038/s41420-025-02852-8
UR  - https://doi.org/10.1038/s41420-025-02852-8
ER  -

APA

C, D., M, M., A, C., R, L., B, B., S, B., A, A., N, P., R, S., L, A., B, S., F, L., T, R., C, C., C, B., R, P., D, P., JC, B., MT, D., P, G., E, M., M, R., DA, P., & S, B. (2025). Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.. Cell death discovery. https://doi.org/10.1038/s41420-025-02852-8

Source records

pubmed · retrieved 2026-11-10T13:40:24.681Z